Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 8.12
Adjusted Patient Survival, Kidney-Pancreas Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
1,651
98.0%
0.3%
1,651
96.2%
0.5%
5,159
87.8%
0.6%
9,709
72.0%
0.7%
Transplant Center State
Alabama
23
+
+
23
+
+
93
90.7%
4.1%
172
70.4%
5.7%
Arkansas
3
+
+
3
+
+
15
93.2%
6.3%
41
63.0%
11.4%
Arizona
75
98.7%
1.3%
75
94.8%
2.5%
149
90.7%
2.8%
216
77.2%
4.7%
California
174
98.4%
0.9%
174
96.7%
1.3%
622
89.6%
1.5%
1,169
75.4%
1.9%
Colorado
34
+
+
34
+
+
77
94.6%
3.0%
148
74.5%
5.4%
Connecticut
2
56.3%
24.8%
2
56.3%
24.8%
9
88.6%
10.1%
24
69.5%
10.3%
District of Columbia
13
93.2%
6.3%
13
93.2%
6.3%
49
86.8%
5.0%
110
72.7%
5.1%
Florida
130
98.6%
1.0%
130
97.1%
1.4%
417
87.8%
1.9%
674
71.2%
2.9%
Georgia
62
98.4%
1.6%
62
98.4%
1.6%
160
87.5%
3.4%
294
76.6%
3.4%
Hawaii
5
+
+
5
+
+
12
83.2%
10.4%
19
80.3%
10.3%
Iowa
13
100.0%
0.0%
13
92.8%
6.6%
46
90.8%
4.3%
113
81.4%
4.4%
Illinois
74
+
+
74
+
+
319
86.7%
2.2%
655
69.1%
2.7%
Indiana
55
+
+
55
+
+
166
87.1%
3.3%
202
73.9%
6.1%
Kansas
22
100.0%
0.0%
22
96.0%
3.8%
41
92.0%
4.4%
105
75.0%
5.8%
Kentucky
23
95.7%
4.1%
23
87.1%
6.8%
69
82.2%
5.3%
155
60.1%
5.9%
Louisiana
49
98.0%
2.0%
49
93.9%
3.4%
149
84.6%
3.5%
255
66.7%
4.9%
Massachusetts
6
100.0%
0.0%
6
85.7%
12.0%
23
95.6%
4.2%
46
74.3%
8.5%
Maryland
40
97.5%
2.4%
40
97.5%
2.4%
125
86.9%
4.1%
225
61.4%
4.9%
Maine
2
+
+
2
+
+
12
90.9%
8.3%
14
92.2%
7.2%
Michigan
33
91.4%
4.7%
33
91.4%
4.7%
114
89.4%
3.1%
171
78.5%
4.6%
Minnesota
34
94.8%
3.5%
34
94.8%
3.5%
115
79.0%
4.2%
317
67.3%
3.2%
Missouri
26
96.4%
3.5%
26
96.4%
3.5%
76
76.6%
7.0%
118
68.9%
5.4%
North Carolina
88
99.0%
1.0%
88
97.9%
1.4%
215
89.7%
2.5%
363
73.1%
3.6%
North Dakota
5
83.4%
13.6%
5
83.4%
13.6%
17
87.0%
8.4%
20
84.3%
8.2%
Nebraska
22
100.0%
0.0%
22
95.8%
4.0%
51
88.8%
4.8%
107
89.8%
3.9%
New Hampshire
8
+
+
8
+
+
13
+
+
13
+
+
New Jersey
45
95.7%
3.0%
45
91.4%
4.1%
112
84.9%
4.3%
187
68.7%
5.2%
Nevada
0
-
-
0
-
-
1
+
+
9
88.7%
10.1%
New York
28
96.7%
3.2%
28
93.4%
4.4%
106
84.5%
4.0%
236
71.4%
3.8%
Ohio
117
98.4%
1.1%
117
95.3%
1.9%
340
82.1%
2.7%
640
65.9%
2.8%
Oklahoma
7
+
+
7
+
+
32
91.6%
5.7%
55
75.9%
8.3%
Oregon
17
+
+
17
+
+
52
91.2%
4.9%
88
87.6%
4.5%
Pennsylvania
47
+
+
47
+
+
249
87.7%
2.3%
603
69.5%
2.6%
Puerto Rico
12
92.0%
7.3%
12
92.0%
7.3%
12
91.7%
7.6%
12
91.5%
7.7%
Rhode Island
1
+
+
1
+
+
6
55.5%
20.6%
6
56.4%
20.5%
South Carolina
27
96.3%
3.6%
27
96.3%
3.6%
68
94.8%
3.0%
147
74.4%
4.8%
South Dakota
0
-
-
0
-
-
2
+
+
2
+
+
Tennessee
38
92.6%
4.1%
38
87.6%
5.1%
117
88.4%
3.3%
251
67.0%
4.0%
Texas
110
97.4%
1.5%
110
95.6%
1.9%
296
85.7%
2.5%
535
74.5%
2.8%
Utah
19
+
+
19
+
+
63
90.7%
4.6%
105
81.4%
5.5%
Virginia
26
100.0%
0.0%
26
96.5%
3.3%
81
89.5%
3.5%
164
78.6%
4.1%
Vermont
12
+
+
12
+
+
23
95.7%
4.1%
23
95.7%
4.1%
Washington
37
97.4%
2.6%
37
97.4%
2.6%
125
95.7%
1.9%
245
73.6%
4.3%
Wisconsin
87
98.9%
1.1%
87
96.7%
1.9%
320
91.1%
1.9%
655
73.8%
2.7%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Patient survival follows patients from first transplant of this type until death.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on Kidney-Pancreas transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.